Related Experiment Video
Updated: Nov 11, 2025

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
Computational Analysis of Residue-Specific Binding Free Energies of Androgen Receptor to Ligands
Guangfeng Shao1, Jingxiao Bao1, Xiaolin Pan1
1Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, Shanghai Key Laboratory of Green Chemistry and Chemical Process, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China.
Abstract:
Androgen receptor (AR) is an important therapeutic target for the treatment of diseases such as prostate cancer, hypogonadism, muscle wasting, etc. In this study, the complex structures of the AR ligand-binding domain (LBD) with fifteen ligands were analyzed by molecular dynamics simulations combined with the alanine-scanning-interaction-entropy method (ASIE). The quantitative free energy contributions of the pocket residues were obtained and hotspot residues are quantitatively identified. Our calculation shows that that these hotspot residues are predominantly hydrophobic and their interactions with binding ligands are mainly van der Waals interactions. The total binding free energies obtained by summing over binding contributions by individual residues are in good correlation with the experimental binding data. The current quantitative analysis of binding mechanism of AR to ligands provides important insight on the design of future inhibitors.
Insights
Researchers quantitatively identified key hydrophobic residues in the androgen receptor (AR) ligand-binding domain (LBD) crucial for drug design. These hotspot interactions, mainly van der Waals forces, correlate well with experimental data, aiding future inhibitor development.
Area of Science:
- Molecular pharmacology and computational chemistry.
Background:
- The androgen receptor (AR) is a critical therapeutic target for diseases including prostate cancer, hypogonadism, and muscle wasting.
- Understanding AR-ligand interactions is essential for developing effective treatments.
Purpose of the Study:
- To quantitatively analyze the binding mechanisms between the AR ligand-binding domain (LBD) and fifteen different ligands.
- To identify hotspot residues within the AR LBD that significantly contribute to ligand binding.
- To provide insights for the rational design of novel AR inhibitors.
Main Methods:
- Employed molecular dynamics simulations.
- Utilized the alanine-scanning-interaction-entropy (ASIE) method to calculate quantitative free energy contributions of pocket residues.
- Analyzed complex structures of the AR LBD with fifteen ligands.
Main Results:
- Quantitatively identified hotspot residues within the AR LBD.
- Found that these hotspot residues are predominantly hydrophobic.
- Demonstrated that the primary interactions between hotspot residues and ligands are van der Waals forces.
- Observed a good correlation between calculated total binding free energies and experimental binding data.
Conclusions:
- The study provides a quantitative analysis of the AR-ligand binding mechanism.
- Identified key hydrophobic residues and van der Waals interactions as critical for binding.
- Findings offer valuable insights for the design of future AR-targeted therapeutics.
More Related Videos
Related Concept Videos
The Equilibrium Binding Constant and Binding Strength
The Equilibrium Binding Constant and Binding Strength
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...

